Literature DB >> 10427999

Prostaglandin E2 inhibits T cell activation-induced apoptosis and Fas-mediated cellular cytotoxicity by blockade of Fas-ligand induction.

B O Porter1, T R Malek.   

Abstract

Prostanoids exhibit both pro-apoptotic and anti-apoptotic functions depending on the maturation stage and tissue localization of target cells. Prostaglandin (PG) E2 has been shown to protect T lymphocytes from TCR-mediated activation-induced cell death, but the mechanism by which PGE2 inhibits apoptosis of T cells has not been established. We show that this protection involves the down-regulation of Fas-ligand (Fas-L) mRNA levels in T cells. Modulation of cell surface Fas-L expression by physiological concentrations of PGE2 was shown to be both anti-apoptotic as well as capable of inhibiting Fas-L-mediated cytotoxicity of Fas-transfected P815 target cells. Thus, this study provides direct evidence of the likely biological means by which PGE2 down-regulates T cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10427999     DOI: 10.1002/(SICI)1521-4141(199907)29:07<2360::AID-IMMU2360>3.0.CO;2-A

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

Review 1.  Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.

Authors:  Jocelyn Reader; Dawn Holt; Amy Fulton
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  Distinct temporal programming of naive CD4+ T cells for cell division versus TCR-dependent death susceptibility by antigen-presenting macrophages.

Authors:  Adam G Schrum; Ed Palmer; Laurence A Turka
Journal:  Eur J Immunol       Date:  2005-02       Impact factor: 5.532

Review 3.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

4.  Elevated expression of prostaglandin receptor and increased release of prostaglandin E2 maintain the survival of CD45RO+ T cells in the inflamed human pleural space.

Authors:  Elisabetta Pace; Tony F Bruno; Byron Berenger; Christopher H Mody; Mario Melis; Maria Ferraro; Annalisa Tipa; Andreina Bruno; Mirella Profita; Giovanni Bonsignore; Mark Gjomarkaj
Journal:  Immunology       Date:  2007-04-26       Impact factor: 7.397

5.  Dendritic cell differentiation with prostaglandin E results in selective attenuation of the extracellular signal-related kinase pathway and decreased interleukin-23 production.

Authors:  Fumie Hayashi; Yoshiki Yanagawa; Kazunori Onoé; Kazuya Iwabuchi
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

6.  Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.

Authors:  Vladimir N Ivanov; Tom K Hei
Journal:  Exp Cell Res       Date:  2006-02-17       Impact factor: 3.905

7.  Lipopolysaccharide activates innate immune responses in murine intestinal myofibroblasts through multiple signaling pathways.

Authors:  Kristen L W Walton; Lisa Holt; R Balfour Sartor
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-08       Impact factor: 4.052

8.  Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways.

Authors:  Steven K Huang; Eric S White; Scott H Wettlaufer; Heather Grifka; Cory M Hogaboam; Victor J Thannickal; Jeffrey C Horowitz; Marc Peters-Golden
Journal:  FASEB J       Date:  2009-08-11       Impact factor: 5.191

9.  Proinflammatory and immunoregulatory roles of eicosanoids in T cells.

Authors:  Anna Mari Lone; Kjetil Taskén
Journal:  Front Immunol       Date:  2013-06-04       Impact factor: 7.561

10.  Prostaglandins and rheumatoid arthritis.

Authors:  Mohammad Javad Fattahi; Abbas Mirshafiey
Journal:  Arthritis       Date:  2012-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.